aTYR PHARMA INC
ATYR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001339970
No open-market purchases or sales by aTYR PHARMA INC insiders were filed in the last 90 days; 89 institutions reported holding it in 13F filings for Q2 2026, worth $23.2M in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in aTYR PHARMA INC as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 36
- −5 vs. Q1 2022
- Shares held
- 18.8M
- −859.3K (−4.4%) vs. Q1 2022
- Total value
- $53.1M
- −$51.9M (−49.4%) vs. Q1 2022
- New holders
- 5
- 8 more added
- Sold out
- 10
- 10 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ATYR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 89 | $23.2M |
| Q1 2026 | 111 | $43.7M |
| Q4 2025 | 84 | $42.1M |
| Q3 2025 | 103 | $43.9M |
| Q2 2025 | 110 | $336.5M |
| Q1 2025 | 87 | $186.5M |
| Q4 2024 | 77 | $198.6M |
| Q3 2024 | 56 | $84.3M |
| Q2 2024 | 47 | $75.1M |
| Q1 2024 | 56 | $81.5M |
| Q4 2023 | 46 | $58.1M |
| Q3 2023 | 41 | $58.7M |
| Q2 2023 | 41 | $77.0M |
| Q1 2023 | 37 | $72.8M |
| Q4 2022 | 36 | $40.2M |
| Q3 2022 | 33 | $57.2M |
| Q2 2022 | 36 | $53.1M |
| Q1 2022 | 41 | $105.0M |
| Q4 2021 | 47 | $153.5M |
| Q3 2021 | 42 | $172.1M |
| Q2 2021 | 29 | $33.8M |
| Q1 2021 | 25 | $26.3M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding aTYR PHARMA INC; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Charter Oak Capital Management, LLC | 150 | $0 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 544 | $1.00K | 0.00% | −790−59.2% | Reduced |
| RE Dickinson Investment Advisors, LLC | 300 | $1.00K | 0.00% | 00.0% | Unchanged |
| PFS Partners, LLC | 406 | $1.15K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 1,675 | $4.00K | 0.00% | +16+1.0% | Added |
| UBS Group AG | 2,000 | $6.00K | 0.00% | −2,000−50.0% | Reduced |
| Group One Trading, L.P. | 5,648 | $16.0K | 0.00% | +5,648 | New |
| Tocqueville Asset Management L.P. | 10,150 | $29.0K | 0.00% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 10,000 | $29.0K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 10,157 | $29.0K | 0.00% | +10,157 | New |
| D.A. Davidson & Co. | 10,800 | $31.0K | 0.00% | +10,800 | New |
| Virtu Financial LLC | 12,845 | $36.0K | 0.00% | −281−2.1% | Reduced |
| Acadian Asset Management LLC | 19,963 | $57.0K | 0.00% | +19,963 | New |
| Tower Research Capital LLC (TRC) | 21,815 | $62.0K | 0.00% | +20,792+2,032.5% | Added |
| Ensign Peak Advisors, Inc | 37,884 | $107.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 45,871 | $130.0K | 0.00% | +1,465+3.3% | Added |
| Susquehanna International Group, LLP | 46,539 | $132.0K | 0.00% | +46,539 | New |
| State Street Corp | 82,908 | $235.0K | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 147,596 | $418.0K | 0.00% | −54,688−27.0% | Reduced |
| Renaissance Technologies LLC | 150,825 | $427.0K | 0.00% | +39,970+36.1% | Added |
| Marshall Wace, LLP | 159,407 | $450.0K | 0.00% | −43,600−21.5% | Reduced |
| Two Sigma Investments, LP | 178,557 | $505.0K | 0.00% | −56,680−24.1% | Reduced |
| Two Sigma Advisers, LP | 183,950 | $521.0K | 0.00% | −13,600−6.9% | Reduced |
| Geode Capital Management, LLC | 238,809 | $675.0K | 0.00% | +4,487+1.9% | Added |
| BlackRock Inc. | 270,157 | $765.0K | 0.00% | −6,002−2.2% | Reduced |
| Deep Track Capital, LP | 290,844 | $823.0K | 0.06% | −737,671−71.7% | Reduced |
| Baker Bros. Advisors LP | 374,395 | $1.06M | 0.01% | −250,605−40.1% | Reduced |
| Telemetry Investments, L.L.C. | 447,000 | $1.26M | 1.93% | +164,580+58.3% | Added |
| Stonepine Capital Management, LLC | 601,580 | $1.70M | 0.79% | 00.0% | Unchanged |
| Alyeska Investment Group, L.P. | 972,326 | $2.75M | 0.03% | +211,528+27.8% | Added |
| Tang Capital Management LLC | 1,113,453 | $3.15M | 0.48% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,139,533 | $3.23M | 0.00% | 00.0% | Unchanged |
| Tikvah Management LLC | 1,350,833 | $3.82M | 1.65% | 00.0% | Unchanged |
| VR Adviser, LLC | 1,398,889 | $3.96M | 0.78% | 00.0% | Unchanged |
| FMR LLC | 4,208,437 | $11.9M | 0.00% | +39,068+0.9% | Added |
| Federated Hermes, Inc. | 5,222,250 | $14.8M | 0.04% | 00.0% | Unchanged |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −159,921−100.0% | Sold out |
| Ikarian Capital, LLC | 0 | $0 | 0.00% | −37,017−100.0% | Sold out |
| Wolverine Trading, LLC | 0 | $0 | 0.00% | −22,089−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −18,808−100.0% | Sold out |
| Ameriprise Financial Inc | 0 | $0 | 0.00% | −15,700−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −13,456−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −650−100.0% | Sold out |
| Raleigh Capital Management Inc. | 0 | $0 | 0.00% | −600−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −72−100.0% | Sold out |
| Cutler Group LP | 0 | $0 | 0.00% | −85−100.0% | Sold out |